Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chapuis

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Blood|February 8, 2019
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapyKevin A Hay, Jordan Gauthier, Alexandre V Hirayama, et al.
Blood|September 23, 2020
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignanciesJordan Gauthier, Evandro D Bezerra, Alexandre V Hirayama, et al.
Nature Communications|January 3, 2026
A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligandsShihong Zhang, Tzu-Hao Tang, Sinéad Kinsella, et al.
Blood|April 29, 2024
HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F Krakow, Michelle Brault, Corinne Summers, et al.
Blood|February 21, 2019
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cellsAlexandre V Hirayama, Jordan Gauthier, Kevin A Hay, et al.
Transplantation and Cellular Therapy|September 10, 2025
Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 TrialsAndrew J Portuguese, Sherilyn A Tuazon, Margot J Pont, et al.
Nature Immunology|December 6, 2023
Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8<sup>+</sup> T cells in persons with previous COVID-19Emily S Ford, Koshlan Mayer-Blackwell, Lichen Jing, et al.
Science Translational Medicine|February 9, 2022
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependencyMiranda C Lahman, Thomas M Schmitt, Kelly G Paulson, et al.
Blood Advances|December 3, 2024
Development and validation of predictive models of early immune effector cell-associated hematotoxicityEmily C Liang, Jennifer J Huang, Andrew J Portuguese, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Blood|February 8, 2019
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapyKevin A Hay, Jordan Gauthier, Alexandre V Hirayama, et al.
Blood|September 23, 2020
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignanciesJordan Gauthier, Evandro D Bezerra, Alexandre V Hirayama, et al.
Nature Communications|January 3, 2026
A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligandsShihong Zhang, Tzu-Hao Tang, Sinéad Kinsella, et al.
Blood|April 29, 2024
HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F Krakow, Michelle Brault, Corinne Summers, et al.
Blood|February 21, 2019
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cellsAlexandre V Hirayama, Jordan Gauthier, Kevin A Hay, et al.
Transplantation and Cellular Therapy|September 10, 2025
Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 TrialsAndrew J Portuguese, Sherilyn A Tuazon, Margot J Pont, et al.
Nature Immunology|December 6, 2023
Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8<sup>+</sup> T cells in persons with previous COVID-19Emily S Ford, Koshlan Mayer-Blackwell, Lichen Jing, et al.
Science Translational Medicine|February 9, 2022
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependencyMiranda C Lahman, Thomas M Schmitt, Kelly G Paulson, et al.
Blood Advances|December 3, 2024
Development and validation of predictive models of early immune effector cell-associated hematotoxicityEmily C Liang, Jennifer J Huang, Andrew J Portuguese, et al.
Pageof 16